Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine.

Details

Ressource 1Download: REF.pdf (237.49 [Ko])
State: Public
Version: Final published version
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_9DCEB3C7D983
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine.
Journal
European Journal of Nuclear Medicine and Molecular Imaging
Author(s)
Perillo-Adamer F., Delaloye A.B., Genton C.S., Schaffland A.O., Dupertuis Y.M., Buchegger F.
ISSN
1619-7070
Publication state
Published
Issued date
05/2006
Peer-reviewed
Oui
Volume
33
Number
5
Pages
613-620
Language
english
Notes
Publication types: Comparative Study ; Journal Article. - Old month value: May
Abstract
PURPOSE: Radio-iododeoxyuridine (IdUrd) is a potential Auger radiation therapy agent incorporated into DNA during the synthesis phase. In this study we sought to optimise S-phase targeting by modulating cellular cycling and radio-IdUrd DNA incorporation using short non-toxic fluorodeoxyuridine (FdUrd) incubations. METHODS: Three human glioblastoma cell lines with different p53 expression were pre-treated with various FdUrd conditions. After different intervals, (125)I-IdUrd DNA incorporation was measured. Fluorescence-activated cell sorter cell cycle analysis was performed after identical intervals post FdUrd pre-treatment. RESULTS: The highest increase in (125)I-IdUrd DNA incorporation was induced by 1-h incubation with 1 muM FdUrd. Increase in radio-IdUrd DNA incorporation was greatest 16-24 h after FdUrd, reaching factors of >or=7.5 over baseline incorporation in the three cell lines. Furthermore, cell synchronisation in S phase was observed with a peak of >or=69.5% in the three cell lines at 16 and 24 h post FdUrd, corresponding to an increase of 2.5-4.1 over baseline. CONCLUSION: FdUrd-induced thymidine synthesis inhibition led to S-phase accumulation that was maximal after an interval of 16-24 h and time-correlated with the highest radio-IdUrd DNA incorporation. These observations might allow the rational design of an Auger radiation therapy targeting a maximal number of S-phase cells in single treatment cycles.
Keywords
Cell Cycle/drug effects, Cell Cycle/radiation effects, Cell Line, Tumor, Dose-Response Relationship, Drug, Floxuridine/administration & dosage, Glioblastoma/metabolism, Glioblastoma/pathology, Humans, Idoxuridine/pharmacokinetics, Iodine Radioisotopes/pharmacokinetics, Metabolic Clearance Rate/drug effects, Radiopharmaceuticals/pharmacokinetics
Pubmed
Web of science
Open Access
Yes
Create date
25/01/2008 11:28
Last modification date
14/02/2022 7:56
Usage data